{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:36:13Z","timestamp":1791657373122,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cbi.2020.108968","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T19:40:37Z","timestamp":1580240437000},"page":"108968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type \u2161 collagen and aggrecan in human SW1353 chondrocytes"],"prefix":"10.1016","volume":"322","author":[{"given":"Hai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.berh.2009.08.006","article-title":"Why is osteoarthritis an age-related disease?","volume":"24","author":"Anderson","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2014.01.004","article-title":"The epidemiology of osteoarthritis","volume":"28","author":"Johnson","year":"2014","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.cbi.2020.108968_bib3","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3892\/mmr.2016.5523","article-title":"Trichostatin A increases the TIMP-1\/MMP ratio to protect against osteoarthritis in an animal model of the disease","volume":"14","author":"Qu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2020.108968_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.22203\/eCM.v021a16","article-title":"Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis","volume":"21","author":"Goldring","year":"2011","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.cbi.2020.108968_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopha.2017.04.054","article-title":"Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs)","volume":"91","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cbi.2020.108968_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/rheumatology\/kem376","article-title":"Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes","volume":"47","author":"Nah","year":"2008","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.cbi.2020.108968_bib7","first-page":"70","article-title":"The effect of Glycirrhiza glabra on osteoarthritis: suppression of TNF-a, IL-1b, Cox-2, iNOS gene expression and prostaglandin E2 and nitric oxide production in chondrocytes and monocyte\/macrophages","volume":"1","author":"Loni","year":"2017","journal-title":"Health Biotech. Biopharm."},{"issue":"3","key":"10.1016\/j.cbi.2020.108968_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jfmk2030027","article-title":"A role for soluble IL-6 receptor in osteoarthritis","volume":"2","author":"Akeson","year":"2017","journal-title":"J. Funct. Morphol. Kinesiol."},{"issue":"2","key":"10.1016\/j.cbi.2020.108968_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13684730050515796","article-title":"Interleukin\u20136 and interleukin\u20138 levels in serum and synovial fluid of patients with osteoarthritis","volume":"6","author":"Kaneko","year":"2000","journal-title":"Cytokines Cell Mol. Ther."},{"key":"10.1016\/j.cbi.2020.108968_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jor.23083","article-title":"Advanced glycation end\u2010products induced VEGF production and inflammatory responses in human synoviocytes via RAGE\u2010NF\u2010\u03baB pathway activation","volume":"34","author":"Chen","year":"2016","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2020.108968_bib13","doi-asserted-by":"crossref","unstructured":"Kim JK. Endothelial nuclear factor \u03baB in obesity and aging: is endothelial nuclear factor \u03baB a master regulator of inflammation and insulin resistance? Circulation 125(9):1081-1083.","DOI":"10.1161\/CIRCULATIONAHA.111.090134"},{"issue":"6","key":"10.1016\/j.cbi.2020.108968_bib14","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cbi.2020.108968_bib15","first-page":"790","article-title":"Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes","volume":"12","author":"Jimenez-Solem","year":"2010","journal-title":"Curr. Opin. Mol. Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2042018814559725","article-title":"GLP-1 receptor agonists: a review of head-to-head clinical studies","volume":"6","author":"Trujillo","year":"2015","journal-title":"Ther. Adv. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib17","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1038\/s41598-017-02838-2","article-title":"GLP-1 receptor signalling promotes \u03b2-cell glucose metabolism via mTOR-dependent HIF-1\u03b1 activation","volume":"7","author":"Carlessi","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.cbi.2020.108968_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/bph.13449","article-title":"Protection against cardiac hypertrophy by geniposide involves the GLP\u20101 receptor\/AMPK \u03b1 signalling pathway","volume":"173","author":"Ma","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2020.108968_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2016.05.086","article-title":"GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR pathway","volume":"476","author":"He","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2020.108968_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2018.03.004","article-title":"The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis","volume":"131","author":"Li","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jdiacomp.2016.02.016","article-title":"Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis","volume":"30","author":"Williams","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.cbi.2020.108968_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabres.2016.10.021","article-title":"Osteoarthritis and type 2 diabetes mellitus: what are the links?","volume":"122","author":"Courties","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2020.108968_bib24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/dc14-1625","article-title":"Efficacy and safety of once-weekly dulaglutide versus insulin Glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)","volume":"38","author":"Giorgino","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.cbi.2020.108968_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s13300-019-00709-9","article-title":"Efficacy of dulaglutide as a first injectable option for patients with type 2 diabetes: a post-hoc pooled analysis","volume":"10","author":"Patel","year":"2019","journal-title":"Diabetes Ther."},{"issue":"4","key":"10.1016\/j.cbi.2020.108968_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14712598.2017.1296131","article-title":"Dulaglutide for the treatment of type 2 diabetes","volume":"17","author":"Scheen","year":"2017","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.cbi.2020.108968_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.abb.2019.07.008","article-title":"Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation","volume":"671","author":"Luo","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2020.108968_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2019.09.021","article-title":"Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: an implication in the treatment of atherosclerosis","volume":"116","author":"Chang","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cbi.2020.108968_bib29","doi-asserted-by":"crossref","first-page":"105649","DOI":"10.1016\/j.intimp.2019.05.034","article-title":"Dulaglutide mitigates inflammatory response in fibroblast-like synoviocytes","volume":"74","author":"Zheng","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2020.108968_bib30","first-page":"838","article-title":"High-mobility group box 1 protein is implicated in advanced glycation end roducts-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5","volume":"18","author":"Lee","year":"2012","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.cbi.2020.108968_bib31","doi-asserted-by":"crossref","first-page":"R1785","DOI":"10.1152\/ajpregu.00519.2009","article-title":"Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats","volume":"297","author":"Raab","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"11","key":"10.1016\/j.cbi.2020.108968_bib32","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3346\/jkms.2010.25.11.1626","article-title":"Exendin-4 protects oxidative stress-induced \u03b2-cell apoptosis through reduced JNK and GSK3\u03b2 activity","volume":"25","author":"Kim","year":"2010","journal-title":"J. Kor. Med. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2020.108968_bib33","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/en.2012-1983","article-title":"Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome","volume":"154","author":"Padmasekar","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1479-5876-11-270","article-title":"Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction","volume":"11","author":"Chen","year":"2013","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.39547","article-title":"Brief report: JNK\u20102 controls aggrecan degradation in murine articular cartilage and the development of experimental osteoarthritis","volume":"68","author":"Ismail","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cbi.2020.108968_bib36","series-title":"Proteoglycan and Collagen Degradation in Osteoarthritis. InCartilage","first-page":"41","author":"Gauci","year":"2017"},{"key":"10.1016\/j.cbi.2020.108968_bib37","series-title":"Type II Collagen. In Biochemistry of Collagens, Laminins and Elastin","first-page":"13","author":"Gudmann","year":"2016"},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcp.2010.02.017","article-title":"New molecular targets for the treatment of osteoarthritis","volume":"80","author":"Alcaraz","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2020.108968_bib39","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar2461","article-title":"A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin\u00ae for treatment of osteoarthritis of the knee","volume":"10","author":"Sengupta","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.cbi.2020.108968_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/092986711794940905","article-title":"New hope for the treatment of osteoarthritis through selective inhibition of MMP-13","volume":"18","author":"Li","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2020.108968_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopha.2017.04.054","article-title":"Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs)","volume":"91","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.cbi.2020.108968_bib42","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.23027","article-title":"Double\u2010knockout of ADAMTS\u20104 and ADAMTS\u20105 in mice results in physiologically normal animals and prevents the progression of osteoarthritis","volume":"56","author":"Majumdar","year":"2007","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"10.1016\/j.cbi.2020.108968_bib44","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","article-title":"The role of the chondrocyte in osteoarthritis","volume":"43","author":"Goldring","year":"2000","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/cyto.2002.2006","article-title":"Different chemokines are expressed in human arthritic bone biopsies: IFN-\u03b3 and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts","volume":"20","author":"Lisignoli","year":"2002","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/rheumatology\/keq380","article-title":"Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-\u03baB in human osteoarthritis chondrocytes","volume":"50","author":"Rasheed","year":"2010","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.cbi.2020.108968_bib47","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.bbamcr.2012.08.021","article-title":"Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2\u03b1, p38-MAPK and NF-\u03baB in advanced glycation end products stimulated human chondrocytes","volume":"1823","author":"Rasheed","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jor.23083","article-title":"Advanced glycation end\u2010products induced VEGF production and inflammatory responses in human synoviocytes via RAGE\u2010NF\u2010\u03baB pathway activation","volume":"34","author":"Chen","year":"2016","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib49","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/s41598-017-03759-w","article-title":"IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity","volume":"7","author":"Pearson","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cbi.2020.108968_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/cyto.2002.2006","article-title":"Different chemokines are expressed in human arthritic bone biopsies: IFN-\u03b3 and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts","volume":"20","author":"Lisignoli","year":"2002","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cbi.2020.108968_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/art.27762","article-title":"Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes","volume":"63","author":"El Mansouri","year":"2011","journal-title":"Arthritis Rheum."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719315078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719315078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:58:18Z","timestamp":1757858298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719315078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":51,"alternative-id":["S0009279719315078"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.108968","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type \u2161 collagen and aggrecan in human SW1353 chondrocytes","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.108968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108968"}}